300636 Stock Overview
Manufactures and sells APIs worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 300636 from our risk checks.
Jiangxi Synergy Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.32 |
| 52 Week High | CN¥11.94 |
| 52 Week Low | CN¥5.76 |
| Beta | -0.00035 |
| 11 Month Change | -5.67% |
| 3 Month Change | 4.26% |
| 1 Year Change | -29.73% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -42.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300636 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.2% | -1.5% | -2.1% |
| 1Y | -29.7% | -9.4% | 2.8% |
Return vs Industry: 300636 underperformed the CN Pharmaceuticals industry which returned -4.8% over the past year.
Return vs Market: 300636 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
| 300636 volatility | |
|---|---|
| 300636 Average Weekly Movement | 8.5% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 300636 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300636's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 1,362 | Zhengwei Pang | www.jxsynergy.com |
Jiangxi Synergy Pharmaceutical Co., Ltd. manufactures and sells APIs worldwide. It offers raw materials, pharmaceutical intermediates, and fine chemicals. Jiangxi Synergy Pharmaceutical Co., Ltd.
Jiangxi Synergy Pharmaceutical Co., Ltd. Fundamentals Summary
| 300636 fundamental statistics | |
|---|---|
| Market cap | CN¥3.48b |
| Earnings (TTM) | CN¥123.07m |
| Revenue (TTM) | CN¥732.41m |
28.3x
P/E Ratio4.7x
P/S RatioIs 300636 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300636 income statement (TTM) | |
|---|---|
| Revenue | CN¥732.41m |
| Cost of Revenue | CN¥495.31m |
| Gross Profit | CN¥237.10m |
| Other Expenses | CN¥114.04m |
| Earnings | CN¥123.07m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.29 |
| Gross Margin | 32.37% |
| Net Profit Margin | 16.80% |
| Debt/Equity Ratio | 32.3% |
How did 300636 perform over the long term?
See historical performance and comparison